fda on compounded semaglutide ends shortage, closing the door Wegovy, Ozempic Compounded Semaglutide for Weight Loss
Description
J no estmago, o GLP-1 reduz a velocidade da digesto da comida e, no crebro, ativa a sensao de saciedade
They want to make sure that using this treatment remains a safe choice
This is my understanding and Im hoping you can add clarity or potentially make a post addressing these concerns
See details and protocol in this application note: Measuring Insulin Release Following GLP-1 Receptor Agonist Treatment Using the Lumit Insulin Immunoassay
Retatrutides connection to dysesthesiaskin tingling or burningstrikes me as particularly notable
